DK1311679T3 - Fremgangsmåde til inhibering af IL-22-induceret PAP1 - Google Patents

Fremgangsmåde til inhibering af IL-22-induceret PAP1

Info

Publication number
DK1311679T3
DK1311679T3 DK01946010T DK01946010T DK1311679T3 DK 1311679 T3 DK1311679 T3 DK 1311679T3 DK 01946010 T DK01946010 T DK 01946010T DK 01946010 T DK01946010 T DK 01946010T DK 1311679 T3 DK1311679 T3 DK 1311679T3
Authority
DK
Denmark
Prior art keywords
pap1
inhibiting
induced
induced pap1
Prior art date
Application number
DK01946010T
Other languages
Danish (da)
English (en)
Inventor
Audrey Goddard
Austin L Gurney
William I Wood
Sudeepta Aggarwal
Jessica S Foster
Ellen M Maruoka
Ming-Hong Xie
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56290147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1311679(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2001/017443 external-priority patent/WO2002016611A2/en
Application granted granted Critical
Publication of DK1311679T3 publication Critical patent/DK1311679T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01946010T 2000-08-24 2001-05-30 Fremgangsmåde til inhibering af IL-22-induceret PAP1 DK1311679T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017443 WO2002016611A2 (en) 2000-08-24 2001-05-30 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

Publications (1)

Publication Number Publication Date
DK1311679T3 true DK1311679T3 (da) 2009-02-23

Family

ID=56290147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01946010T DK1311679T3 (da) 2000-08-24 2001-05-30 Fremgangsmåde til inhibering af IL-22-induceret PAP1

Country Status (6)

Country Link
EP (1) EP1311679B1 (enExample)
JP (1) JP3886899B2 (enExample)
AU (1) AU2001268108A1 (enExample)
CA (1) CA2419541C (enExample)
DK (1) DK1311679T3 (enExample)
ES (1) ES2316454T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006082851A1 (ja) * 2005-02-02 2008-06-26 国立大学法人 東京大学 エピグリカニン関連ムチン
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
WO2018097646A1 (ko) * 2016-11-24 2018-05-31 이형근 질환의 진단용 조성물
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물

Also Published As

Publication number Publication date
ES2316454T3 (es) 2009-04-16
CA2419541C (en) 2012-01-10
JP3886899B2 (ja) 2007-02-28
JP2004520811A (ja) 2004-07-15
AU2001268108A1 (en) 2002-03-04
EP1311679A2 (en) 2003-05-21
EP1311679B1 (en) 2008-10-22
CA2419541A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
DK1132569T3 (da) Fremgangsmåde til behandling af en underjordisk formation
DK1257954T3 (da) Fremgangsmåde til fordeling af forsendelser
DK1312239T3 (da) Teknikker til undertrykkelse af interferens
DK1249151T3 (da) Fremgangsmåde til cellegenvalgssignalering
DK1071745T3 (da) Fremgangsmåde til syntetisering af COX-2-inhibitorer
DK1326841T3 (da) Pyridinon-derivater til behandling af atherosklerose
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DE60211317D1 (de) Rho-kinase inhibitoren
DE60218138D1 (de) Rho-kinase inhibitoren
FI20001160L (fi) Pilottisignaalin toteuttamismenetelmä
DK1132570T3 (da) Sammensætninger til syrebehandling af borebrönde
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
DK1414492T3 (da) Fremgangsmåde til behandling af multipel myeloma
IS6012A (is) Aðferð til útdráttar á málmi
DK1337547T3 (da) Nuklease-baseret fremgangsmåde til detektion og kvantificering af oligonukleotider
DK1314824T3 (da) Fremgangsmåde til konsolidering af jord
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1309323T3 (da) Fremgangsmåde til behandling af angiogeneserelaterede lidelser
DK1169271T3 (da) Fremgangsmåde til remediering af vandförende lag
DK1066276T3 (da) Fremgangsmåde til syntese af HIV protease inhibitor
DK1311679T3 (da) Fremgangsmåde til inhibering af IL-22-induceret PAP1
DE60031450D1 (de) Polymorph v von torasemid
DK1400522T3 (da) Forbindelser til behandling af impotens